Phase 2CompletedINTERVENTIONAL
Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer
ClinicalTrials.gov · NCT02274779 · Registry updated: 2026-02-13
- Condition / research focus
- Prostate Cancer
- Sponsor
- Institut Cancerologie de l'Ouest
- Countries with listed sites
- France
- Registry dates and results
- Start: 2014-08-20. Completion: 2024-07-22 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- ELIGARD (drug) — also listed as: Leuproréline
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- ICO Paul Papin
Angers, France
Site recruitment: Not reported - ICO René GauducheauSaint-Herblain, France